Literature DB >> 4027980

Evaluation of growth and histology of human tumor xenografts implanted under the renal capsule of immunocompetent and immunodeficient mice.

J A Bennett, V A Pilon, R T MacDowell.   

Abstract

Fresh surgical explants of human carcinomas were implanted as first transplant generation xenografts under the kidney capsule of mice. Immunocompetent and immune-deficient mice were compared for their ability to support the persistence and growth of these xenografts. Consistent growth of tumor xenografts could not be demonstrated following implantation under the kidney capsule of immunocompetent mice. Immunological infiltration and rejection of the xenografts began 3 days postimplantation, and tumors were largely eliminated from the subcapsular space by 6 days postimplantation. In contrast human tumors consistently grew under the kidney capsule of nude mice. Significant growth became apparent by 9 days postimplantation with most human carcinomas and continued thereafter. Growth was always accompanied by neovascularization of tumor xenografts which was visible by examination of tumor-bearing kidneys under a dissecting microscope (X 6). There was no histological evidence of immunological interference with the persistence and growth of xenografts in nude mice. Thymectomized, irradiated, bone marrow-reconstituted conventional mice, as well as conventional mice, treated daily with 60 mg of cyclosporine A/kg were comparable to nude mice as hosts which supported the long-term persistence and growth of subrenal capsule implants of human tumors. Such mice could provide an alternative to nude mice as hosts in which chemosensitivity assays could be carried out against growing human tumors at a considerable saving in cost and convenience.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4027980

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  A novel method for implantation of LNCaP prostate tumor cells under the renal capsule.

Authors:  R M Adam; A Orsola; M R Freeman
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-06       Impact factor: 2.416

2.  The histological assessment and evaluation of a 4 day subrenal capsule assay by the percentage inhibition of DNA/protein.

Authors:  M Nishiyama; M Hirono; S Takagami; R Kim; T Saeki; Y Kirihara; K Jinushi; E Yanagawa; T Toge; M Niimoto
Journal:  Jpn J Surg       Date:  1989-07

3.  The usefulness of cyclophosphamide pretreatment for subrenal capsule assay against human esophageal cancer.

Authors:  M Terashima; K Ikeda; S Kawamura; C Maesawa; K Ishida; M Sato; K Saito
Journal:  Jpn J Surg       Date:  1991-03

4.  A peptide derived from alpha-fetoprotein prevents the growth of estrogen-dependent human breast cancers sensitive and resistant to tamoxifen.

Authors:  James A Bennett; Fassil B Mesfin; Thomas T Andersen; John F Gierthy; Herbert I Jacobson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-05       Impact factor: 11.205

5.  Maturation of the developing human fetal prostate in a rodent xenograft model.

Authors:  Camelia M Saffarini; Elizabeth V McDonnell; Ali Amin; Daniel J Spade; Susan M Huse; Stefan Kostadinov; Susan J Hall; Kim Boekelheide
Journal:  Prostate       Date:  2013-08-30       Impact factor: 4.104

6.  Comparative analysis of metastasis variants derived from human prostate carcinoma cells: roles in intravasation of VEGF-mediated angiogenesis and uPA-mediated invasion.

Authors:  Erin M Conn; Kenneth A Botkjaer; Tatyana A Kupriyanova; Peter A Andreasen; Elena I Deryugina; James P Quigley
Journal:  Am J Pathol       Date:  2009-09-03       Impact factor: 4.307

7.  Tioconazole and Chloroquine Act Synergistically to Combat Doxorubicin-Induced Toxicity via Inactivation of PI3K/AKT/mTOR Signaling Mediated ROS-Dependent Apoptosis and Autophagic Flux Inhibition in MCF-7 Breast Cancer Cells.

Authors:  Afnan H El-Gowily; Samah A Loutfy; Ehab M M Ali; Tarek M Mohamed; Mohammed A Mansour
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-11

8.  Efficacy of immunoliposomes on cancer models in a cell-surface-antigen-density-dependent manner.

Authors:  S Hosokawa; T Tagawa; H Niki; Y Hirakawa; K Nohga; K Nagaike
Journal:  Br J Cancer       Date:  2003-10-20       Impact factor: 7.640

9.  An alpha-fetoprotein-derived peptide reduces the uterine hyperplasia and increases the antitumour effect of tamoxifen.

Authors:  T T Andersen; J Georgekutty; L A Defreest; G Amaratunga; A Narendran; N Lemanski; H I Jacobson; J A Bennett
Journal:  Br J Cancer       Date:  2007-07-17       Impact factor: 7.640

10.  Establishment of a Human Gastric Cancer Xenograft Model in Immunocompetent Mice Using the Microcarrier-6.

Authors:  Yanzhen Bi; Quanyi Wang; Yonghong Yang; Quanquan Wang; Kai Zhang; Xiaobei Zhang; William C Cho; Zhenfeng Shu; Jiannan Li; Lili Liu; Chuanping Si; Feng Hong
Journal:  Biomed Res Int       Date:  2020-04-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.